Sirnaomics Ltd. (HKG:2257)
Hong Kong
· Delayed Price · Currency is HKD 6.74
+0.27 (4.17%)
At close: Mar 10, 2026
Sirnaomics Market Cap
Sirnaomics has a market cap or net worth of 733.98 million as of March 10, 2026. Its market cap has increased by 155.79% in one year.
Market Cap
733.98M
Enterprise Value
626.89M
Revenue
7.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.74
Market Cap Chart
Since December 30, 2021, Sirnaomics's market cap has decreased from 6.86B to 733.98M, a decrease of -89.30%. That is a compound annual growth rate of -41.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 688.40M | -15.65% |
| Dec 31, 2025 | 816.08M | 126.04% |
| Dec 31, 2024 | 361.03M | -88.38% |
| Dec 29, 2023 | 3.11B | -38.75% |
| Dec 30, 2022 | 5.07B | -36.82% |
| Dec 31, 2021 | 8.03B | 17.07% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Uni-Bio Science Group | 656.84M |
| JW (Cayman) Therapeutics Co. | 778.83M |
| 3D Medicines | 932.46M |
| Sunho Biologics | 971.95M |
| Brii Biosciences | 995.72M |
| Transcenta Holding | 998.76M |
| Wuhan YZY Biopharma | 1.10B |
| Shanghai Bio-heart Biological Technology | 1.20B |